Sensitivity of the Molecular Test in Saliva for Detection of COVID-19 in Pediatric Patients With Concurrent Conditions

• Ngā kaituhi matua: Guzmán-Ortiz Ana Laura (Author), Nevárez-Ramírez Abraham Josué (Author), López-Martínez Briceida (Author), Parra-Ortega Israel (Author), Angeles-Floriano Tania (Author), Martínez-Rodríguez Nancy (Author), Jamaica-Balderas Lourdes (Author), De la Rosa-Zamboni Daniela (Author), Ortega-Riosvelasco Fernando (Author), Jaramillo-Esparza Carlos Mauricio (Author), Bonilla-Pellegrini Sergio René (Author), Reyna-Trinidad Irineo (Author), Márquez-González Horacio (Author), Medina-Contreras Oscar (Author), Quezada Héctor (Author)
• Hōputu: Pukapuka
• I whakaputaina: Frontiers Media S.A., 2021-04-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Background: The reference standard for the molecular diagnostic testing for COVID-19 is the use of nasopharyngeal or combined nasopharyngeal and oropharyngeal (NP/OP) swabs. Saliva has been proposed as a minimally invasive specimen whose collection reduces the risks for health care personnel.Objecti...